Co-founder and chair of the board of directors of CervoMed,
Inc.
Chair of the board of directors of Abivax SA.
Member of the board of directors of F2G Ltd.
Advisor to
Sofinnova Telethon Fund.
President of Human Genetic Therapies Shire PLC, 2007-2013.
Executive chair of IDM Pharma Inc., 2006-2007.
President and chief executive officer in GlycoFi Inc.,
2003-2004.
Considered independent under the Danish Corporate Governance
Recommendations.
Member of the Board of Directors since March
2015. Most recently elected in 2024 for a term of one year.
Member of the Audit Committee since March 2015. The Board has
assessed that Ms Grégoire qualifies as independent pursuant to the
US Securities Exchange Act.
Member of the Research &
Development Committee since March 2017.
Member of
the People and Governance Committee (previously the Nomination
Committee) since March 2018.
Global corporate leadership.
Healthcare and pharma
industry.
Medicine & science.
Finance &
accounting.
Business development, M&A and external
innovation sourcing.
Human capital management.
1986: Pharmacy Doctorate degree, the State University of NY at
Buffalo, US,
1984: BA in Pharmacy, Laval University,
Canada.
1980: Science College degree, Séminaire de
Sherbrooke, Canada.